Market Research Life Sciences Market Research Pharmaceuticals Market Research Therapeutic Area Market Research Reproductive Health Market Research

North America Male Infertility Market 2023-2030

Best Price Guarantee Length Publisher Published Date SKU
from $1,500 111 Pages Triton Market Research July, 2023 TRTN18073120
Best Price Guarantee
Price from $1,500
Length 111 Pages
Publisher Triton Market Research
Published Date July, 2023
SKU TRTN18073120

North America Male Infertility Market 2023-2030



MARKET OUTLOOK

Triton Market Research’s report suggests that the male infertility market in North America is set to garner a compound annual growth rate of 4.41% in revenue over the forecasting years from 2023 to 2030. Canada and the United States are studied in the given region.

In the United States, the demand for assisted reproductive technology (ART) has risen. According to the CDC, around 326,468 ART cycles were conducted at 449 reporting clinics in 2020. Although ART is not yet widely opted for, its usage has gained traction as a viable solution to improve fertility rates. In 2020, approximately 2.0% of all babies born in the US resulted from ART. The number of ART cycles performed in 2021 increased by 19% from 2020. Hence, these factors are expected to further strengthen and promote the growth of the male infertility market in the United States.

Several factors, including a decline in fertility rates and a rise in health conditions, fuel the male infertility market in Canada. In this regard, market players are strategically developing solutions to address these issues, considering the growing burden of smoking, obesity, alcohol consumption, and sedentary lifestyles among the male population. This will further elevate the adoption of advanced male infertility treatments, thereby boosting the market’s development.

COMPETITIVE OUTLOOK

The notable companies in the male infertility market include Halotech DNA, EMD Serono Inc, Endo International Plc, Vitrolife, and Bayer AG.


1. North America Male Infertility Market - Summary
2. Industry Outlook
2.1. Parent Market Analysis
2.2. Impact Analysis On The Male Infertility Market
2.2.1. Covid-19 Impact
2.2.2. Ukraine-russia War Impact
2.3. Porter’s Five Forces Analysis
2.3.1. Threat Of New Entrants
2.3.2. Threat Of Substitutes
2.3.3. Bargaining Power Of Buyers
2.3.4. Bargaining Power Of Suppliers
2.3.5. Threat Of Competitive Rivalry
2.4. Market Maturity Analysis
2.5. Key Market Strategies
2.5.1. Collaborations
2.5.2. Product Launches
2.5.3. Mergers & Acquisitions
2.5.4. Business Divestitures & Expansions
2.6. Market Drivers
2.6.1. Prevalence Of Infertility
2.6.2. Use Of Assisted Reproductive Technologies
2.6.3. Technological Innovations And Advancements
2.7. Market Challenge
2.7.1. High Cost Of Treatment
2.8. Market Opportunities
2.8.1. Increasing Acceptance Of Minimally Invasive Surgeries
2.8.2. Growing Availability Of Infertility Treatment Drugs, Procedures, And Devices
2.8.3. Government Initiatives Toward Improving Reimbursement Policies
2.9. Analyst Perspective
3. North America Male Infertility Market – By Test Type
3.1. Dna Fragmentation Technique
3.2. Oxidative Stress Analysis
3.3. Microscopic Examination
3.4. Sperm Agglutination
3.5. Computer-assisted Semen Analysis
3.6. Sperm Penetration Assay
3.7. Other Test Types
4. North America Male Infertility Market – By Treatment
4.1. Assisted Reproductive Technology And Surgery
4.2. Medications
5. North America Male Infertility Market – By Country Outlook
5.1. Country Analysis
5.1.1. United States
5.1.1.1. United States Male Infertility Market Forecast & Prospects
5.1.2. Canada
5.1.2.1. Canada Male Infertility Market Forecast & Prospects
6. Competitive Landscape
6.1. Halotech Dna
6.1.1. Overview
6.1.2. Product Portfolio
6.2. Emd Serono Inc
6.2.1. Overview
6.2.2. Product Portfolio
6.2.3. Key Strengths
6.2.4. Key Challenges
6.3. Endo International Plc
6.3.1. Overview
6.3.2. Product Portfolio
6.3.3. Key Strengths
6.3.4. Key Challenges
6.4. Vitrolife
6.4.1. Overview
6.4.2. Product Portfolio
6.4.3. Key Strengths
6.4.4. Key Challenges
6.5. Bayer Ag
6.5.1. Overview
6.5.2. Product Portfolio
6.5.3. Key Strengths
6.5.4. Key Challenges
6.6. Aytu Biopharma
6.6.1. Overview
6.6.2. Product Portfolio
6.6.3. Key Strengths
6.6.4. Key Challenges
6.7. Zydus Lifesciences Limited
6.7.1. Overview
6.7.2. Product Portfolio
6.7.3. Key Strengths
6.7.4. Key Challenges
6.8. Cinnagen Co
6.8.1. Overview
6.8.2. Product Portfolio
6.8.3. Key Strengths
6.8.4. Key Challenges
6.9. Sanofi Sa
6.9.1. Overview
6.9.2. Product Portfolio
6.9.3. Key Strengths
6.9.4. Key Challenges
6.10. Laboratory Corporation Of America Holdings
6.10.1. Overview
6.10.2. Product Portfolio
6.10.3. Key Strengths
6.10.4. Key Challenges
7. Research Methodology & Scope
7.1. Research Scope & Deliverables
7.2. Sources Of Data
7.3. Research Methodology
Table List
Table 1: North America Male Infertility Market, By Country Outlook, 2023-2030 (In $ Million)
Table 2: List Of Collaborations
Table 3: List Of Product Launches
Table 4: List Of Mergers & Acquisitions
Table 5: List Of Business Divestitures & Expansions
Table 6: North America Male Infertility Market, By Test Type, 2023-2030 (In $ Million)
Table 7: North America Male Infertility Market, By Treatment, 2023-2030 (In $ Million)
Table 8: North America Male Infertility Market, By Country Outlook, 2023-2030 (In $ Million)
Figure List
Figure 1: Market Maturity Analysis
Figure 2: North America Male Infertility Market, By Type, 2022 & 2030 (In %)
Figure 3: North America Male Infertility Market, By Dna Fragmentation Technique, 2023-2030 (In $ Million)
Figure 4: North America Male Infertility Market, By Oxidative Stress Analysis, 2023-2030 (In $ Million)
Figure 5: North America Male Infertility Market, By Microscopic Examination, 2023-2030 (In $ Million)
Figure 6: North America Male Infertility Market, By Sperm Agglutination, 2023-2030 (In $ Million)
Figure 7: North America Male Infertility Market, By Computer-assisted Semen Analysis, 2023-2030 (In $ Million)
Figure 8: North America Male Infertility Market, By Sperm Penetration Assay, 2023-2030 (In $ Million)
Figure 9: North America Male Infertility Market, By Other Test Types, 2023-2030 (In $ Million)
Figure 10: North America Male Infertility Market, By Treatment, 2022 & 2030 (In %)
Figure 11: North America Male Infertility Market, By Assisted Reproductive Technology And Surgery, 2023-2030 (In $ Million)
Figure 12: North America Male Infertility Market, By Medications, 2023-2030 (In $ Million)
Figure 13: North America Male Infertility Market, By Country Outlook, 2022 & 2030 (In %)
Figure 14: United States Male Infertility Market 2023-2030 (In $ Million)
Figure 15: Canada Male Infertility Market 2023-2030 (In $ Million)

$1,500
$2,200

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings